a borderline significant trendP = 0.06
In our study, a borderline significant trend to a higher benefit from chemotherapy ( P = 0.06) was instead observed for the SOX2 negative cases.
In our study, a borderline significant trend to a higher benefit from chemotherapy ( P = 0.06) was instead observed for the SOX2 negative cases.
MUC2 and SOX2 expression did not show a significant correlation with any of the clinicopathological variables evaluated (Table 2 ), except for a borderline significant association between low expression of MUC2 and moderately/poorly differentiated tumors.